Santa Cruz Biotechnology provides a broad selection of AKR1C19 monoclonal antibodies for research focused on understanding this important enzyme. AKR1C19 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). AKR1C19, a member of the aldo-keto reductase family, plays a crucial role in the metabolism of steroid hormones and xenobiotics. The enzyme actively participates in the reduction of ketones and aldehydes, contributing to the regulation of various physiological processes, including inflammation and cell proliferation. Understanding AKR1C19 function is essential for elucidating potential implications in diseases such as cancer and metabolic disorders. Researchers can utilize AKR1C19 monoclonal antibodies to explore expression patterns across different tissues and cellular compartments. Advanced visualization techniques with AKR1C19 monoclonal antibodies enable detailed analysis of protein localization and interactions. Comprehensive studies of AKR1C19 can reveal new therapeutic targets and pathways. Santa Cruz Biotechnology monoclonal antibodies for AKR1C19 support researchers worldwide in advancing scientific understanding of enzyme function and disease mechanisms.